Home › Companies › Biotechnology, Health Care, Life Science, Medical, Neuroscience › Neurexis Therapeutics
Neurexis Therapeutics
Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.
Neurexis Therapeutics operates in biotechnology, health care, life science, medical, neuroscience based in Greater Denver Area, Western US, founded in 2020.
Its activity falls under biotechnology, health care, life science, medical, neuroscience; the profile below is assembled from public directory data.
The business is associated with Greater Denver Area, Western US.
Its current recorded stage is Grant.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $1.2M.
| Sector | Biotechnology, Health Care, Life Science, Medical, Neuroscience |
|---|---|
| Headquarters | Greater Denver Area, Western US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $1,205,000 |
Website: neurexistherapeutics.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account